1/New study in @DrugAlcoholDep finds that a national Stay-at-Home order for COVID-19 had "variable" impacts on opioid OD-
And it demonstrates that Emergency Dept overdose diagnoses deliver only a very cloudy view on overdose rates, - KY, OH, MA, NY sciencedirect.com/science/articl…!
2/ 3 of 4 states (MA,NY,OH,*not KY*) had a 10 week ⬇️ in ED visits for opioid OD after pandemic hit.
Then, ED visits ⬆️ for MA,OH,KY
**But ED visits don't relate tightly to death**
OD deaths for 2020, relative to 2019:
MA:⬆️2%
NY:⬆️34%
KY:⬆️54%
OH:⬆️22% commonwealthfund.org/blog/2021/drug…
3/Authors conclude what I agree with, but I'll comment.
They say:
"results support our hypothesis of a significant impact of the national stay-at-home order on ED encounters for suspected OOD in the 4 HCS states, but indicate that the dynamics of this impact differed"
YES, and.
4/As the authors say: when care systems were overwhelmed, that suppressed care-seeking, but only for a few weeks in MA
Much more variation - mostly unexplained- is going on here:
5/We face real flaws in use of "Overdose Syndromic surveillance" using hospital &emergency department visits
Such data underdetect OD or are biased, in mostly unknowable ways, by variations in
*care-seeking
*fatality related to variations in drug supply
*poor diagnostic coding
6/This also means that most prescription opioid risk calibration and monitoring tools - useful as they may be (and I personally rely on VA's STORM tool) - over-emphasize ONE subset of overdose and/or suicide events: the ones patients seek care for.
7/If our goal is monitoring health, we will *never have a perfect solution*
But we should supplement health system monitoring with **community surveys** to assess the prevalence of overdose
Our wonderful Birmingham research team has new data soon (+@ChelseaLShover
and others!)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
🧵1/Our @uabmedicine Grand Rounds will feature a diagnostic showdown between Dr Martin Rodriguez and ChatGPT4
I am scared here because I don’t want AI to win
2/the case features behavioral changes, swearing, cognitive decline, cough, progressive weakness over 3 years.
I wonder about infectious and rheumatic disorders. Maybe primary neurological
Aspirations after a cognitive change is possible
Dr Rodriguez opens. Not much to go on.
3/ChatGPT generated a lot of text read by Dr Kraemer but it is pretty good, with emphasis on neurological disorders followed by a disclaimer “please note that this does not substitute for professional medical advice”. Both want more information
Truth💣 1/ The “NARXCare” opioid Rx risk algorithm is in all Prescription Monitoring Databases,ie ~1 bn Rx’s/year
NOW in @JournalGIM
✅evidence does not yet exist to support it as safe or protective
✅It has flourished due to lack of federal oversight link.springer.com/article/10.100…
2/The authors, led by Dr Michele Buonara, review the core argument as one in which this algorithm with low evidence to its favor
and high risk of harm
has gone unregulated
despite apparently fulfilling @US_FDA criteria that mandate it be regulated
3/Nearly all prescribers and national pharmacies now see the Bamboo Health, Inc proprietary “NARXcare” algorithm in a more prominent position *than the prescription history itself” when they view a prescription history.
1/Arguing for methadone deregulation, Dr. Ruth Potee notes that in an auditorium of 400 addiction specialists, almost NONE prescribe methadone (because they can't)
"Methadone is a miracle drug that no one has access to"
There are more people who offer Botox than offer methadone
Patient: “I can still do my activities”.
Doc: "No way, not really. I read the SPACE trial, and there is NO benefit (that would outweigh the opioids’ risk)”
"Shared decision-making" seems *doomed* here
1/I watch with concern as DEA prosecutions of MDs still seem to rely on “they prescribed more than I would” despite a 9-0 ruling of
Supreme Court last year
Sudden termination of opioids & progressive abandonment of 5-8 million patients is dangerous
1/Even on inpatient rounds, it is possible to introduce the idea that addiction isn’t (only) in the brain.
I contrast @NIAAAnews “brain disease” against a behavioral economics vide substance use as a pattern of behavior occurring in relation to environmental context
2/On teaching rounds we read aloud and discussed the @NIAAAnews brain-science model of addiction, pulling just a few lines off their website
3/then we read lines from Chapter 39 of “Evaluating the Brain Disease Model of Addiction” - this presents harmful substance use as a pattern of behavior based on assessment of competing rewards, delay or uncertainty of desired rewards, risks and costs - ie behavioral economics